Found: 2
Select item for more details and to access through your institution.
Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized Phase II trial.
- Published in:
- European Heart Journal, 2015, v. 36, n. 33, p. 2228, doi. 10.1093/eurheartj/ehv254
- By:
- Publication type:
- Article
Administration of a Glycoprotein IIb/IIIa Receptor Blocker with a Thienopyridine Derivative Does Not Increase the Risk of Thrombocytopenia.
- Published in:
- Ohio Journal of Science, 2005, v. 105, n. 4, p. 74
- By:
- Publication type:
- Article